Thrombin Generation Assay for Cancer Associated Thrombosis Research

Posted: April 12, 2022

It’s Not Just Support. It’s Solutions.

diapharma bioassays hemostasis thrombosis chromogenic

Technothrombin® and Ceveron® TGA

Thrombin Generation Testing for Cancer-Associated Thrombosis Research

Thrombosis is a common complication for individuals with cancer. Risk varies by malignancy type, treatment approaches, and individual risk factors. Thrombin generation assays (TGA) provide a global context of thrombosis.

When you want to measure thrombin generation in your cancer research studies, consider the options from DiaPharma to suit your needs.

Technothrombin Ceveron TGA Thrombin Generation Assay ADAMTS13 FXIII Activity Measurement Assay Test Kit

Manual or automated options to suit your needs:

Technothrombin® TGA

  • Give thrombotic potential a number
  • Applications for most fluorescent readers
  • Choose optimized reagents with varying tissue factor and phospholipid concentrations based on your experimental needs

Ceveron® TGA

  • Automated for walk-away TGA
  • Normalized TGA values
  • Convenient kit options – choose reagents with varying tissue factor and phospholipid concentrations based on your experimental needs
  • You name it, Ceveron® s100 can do it!

Visit diapharma.com for our comprehensive portfolio of hemostasis research products.

All Technoclone products are for research use only in the U.S. and Canada. Not for use in diagnostic procedures.

diapharma

Technothrombin Ceveron TGA Thrombin Generation Assay ADAMTS13 FXIII Activity Measurement Assay Test Kit

It’s Not Just Support. It’s Solutions.

Celebrating 25 years of scientific expertise, with support just a call or click away.

diapharma hemostasis bioassay

diapharma

DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069

Technical Support: 1.800.447.3846

ML-00-00910Rev01